VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 19 filers reported holding VIRPAX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $479 | -26.1% | 600 | 0.0% | 0.00% | – |
| Q2 2023 | $648 | +37.6% | 600 | 0.0% | 0.00% | – |
| Q1 2023 | $471 | – | 600 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 600 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 600 | +275.0% | 0.00% | – |
| Q2 2022 | $0 | – | 160 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 160 | +220.0% | 0.00% | – |
| Q4 2021 | $0 | – | 50 | -43.2% | 0.00% | – |
| Q3 2021 | $0 | – | 88 | -1.1% | 0.00% | – |
| Q1 2021 | $0 | – | 89 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 292,790 | $234,203 | 0.17% |
| OSAIC HOLDINGS, INC. | 600 | $479 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 100,875 | $80,700 | 0.00% |
| WELLS FARGO & COMPANY/MN | 63 | $50 | 0.00% |
| NORTHERN TRUST CORP | 15,221 | $12,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 63,928 | $51,170 | 0.00% |
| MORGAN STANLEY | 150 | $120 | 0.00% |
| BlackRock Inc. | 464 | $371 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,220 | $4,976 | 0.00% |